Company News

US STOCKS-S&P 500 clears 3,000 barrier on economic recovery and vaccine hopes

(For a live blog on the U.S. stock market, click or type LIVE/ in a news window.)

* Novavax jumps, to test vaccine candidate on humans

* Beaten down travel-related stocks surge

* Trump is “miffed” with China -Kudlow

* Indexes up: Dow 2.75%, S&P 1.9%, Nasdaq 0.94% (Updates to late afternoon, adds commentary, changes byline, adds New York dateline)

New York, May 26 (Reuters) - U.S. stocks jumped on Tuesday, propelling the S&P 500 past the key psychological level of 3,000 points as optimism about developing coronavirus vaccines and the revival of business activity helped investors overlook simmering China-U.S. tensions.

The benchmark S&P 500 crossed 3,000 for the first time since March 5, but came off session highs after White House adviser Larry Kudlow said President Donald Trump was “so miffed with China on virus and other matters that the trade deal is not as important to him as it once was.”

Still, all 11 S&P sector indexes were higher, with cyclical financials up 5.7% and industrials rising 4.7%.

The S&P 500 has risen about 37% from its March lows on central bank and government stimulus at a time when the U.S. economy is seeing its biggest job losses since the Great Depression of the 1930s. It is now about 11% below its February record high.

On Monday, California, which has had one of the country’s most restrictive shutdowns, said it would allow retail businesses to offer in-store shopping and places of worship to reopen.

“There’s more optimism about the vaccines and all the 50 states have reopened to various degrees,” leading to optimism that the U.S. economy would improve, said John Praveen, portfolio manager at QMA, a PGIM company.

Data showed U.S. consumer confidence nudged up in May, adding to hopes that the worst of the economic impact of the shutdown is in the past.

At 2:05 p.m. ET, the Dow Jones Industrial Average rose 673.38 points, or 2.75%, to 25,138.54, the S&P 500 gained 56.27 points, or 1.90%, to 3,011.72, and the Nasdaq Composite added 87.61 points, or 0.94%, to 9,412.20.

U.S. biotech group Novavax Inc jumped 8% as it joined the race to test coronavirus vaccine candidates on humans and enrolled its first participants. Merck & Co Inc added 2% as it announced plans to develop two separate vaccines.

With macroeconomic data pointing at a deep recession, analysts warned that financial markets could be betting on too fast a recovery.

“The impact on the economy and corporate earnings will be seen for several quarters, (and) I’m not sure if it has been completely baked into the equity prices,” Robert Wyrick, chief investment officer at Post Oak Private Wealth Advisors in Houston, told the Reuters Global Markets Forum.

Beaten-down travel-related stocks soared, with the S&P 1500 airlines index up about 13.4%. Cruise operators including Carnival Corp were more than 13.7%.

The New York Stock Exchange on Tuesday partially reopened its trading floors at the iconic 11 Wall Street building, which had been closed since March 23.

Advancing issues outnumbered declining ones on the NYSE by a 6.68-to-1 ratio; on Nasdaq, a 3.27-to-1 ratio favored advancers.

The S&P 500 posted 13 new 52-week highs and no new lows; the Nasdaq Composite recorded 103 new highs and eight new lows.

Reporting by Sinead Carew in New York; Additional reporting by Medha Singh and Uday Sampath, Lisa Pauline Mattackal in Bengaluru; Editing by Leslie Adler